î
îŒ
î
Drugs Made In America Acquisition Corp
DMAA10.380USD
+0.020+0.19%
ååŒæé ïŒETïŒ15åé
ãã®æ ªäŸ¡
347.89Mæ䟡ç·é¡
94.62çŽè¿12ã¶æPER
î
詳现æ å ± Drugs Made In America Acquisition Corp äŒæ¥å
Drugs Made In America Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The Company intends to focus its search for businesses in the pharmaceutical industry. The Company has neither engaged in any operations nor generated any revenues.
Drugs Made In America Acquisition Corpã®äŒæ¥æ å ±
îäŒæ¥ã³ãŒãDMAA
äŒç€ŸåDrugs Made In America Acquisition Corp
äžå Žæ¥Jan 28, 2025
æé«çµå¶è²¬ä»»è
ãCEOãStockwell (Lynn)
åŸæ¥å¡æ°- -
蚌åžçš®é¡Ordinary Share
決ç®ææ«Jan 28
æ¬ç€Ÿæåšå°1 East Broward Boulevard
éœåžFT LAUDERDALE
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœUnited States of America
éµäŸ¿çªå·33301
é»è©±çªå·19548703099
ãŠã§ããµã€ã
äŒæ¥ã³ãŒãDMAA
äžå Žæ¥Jan 28, 2025
æé«çµå¶è²¬ä»»è
ãCEOãStockwell (Lynn)
Drugs Made In America Acquisition Corpã®çµå¶é£
îäŒç€Ÿå
äŒç€Ÿå/ããžã·ã§ã³
ããžã·ã§ã³
æ ªåŒä¿æ
å€åé¡
Dr. Catherine Do
Dr. Catherine Do
Independent Director Nominee
Independent Director Nominee
100.00K
--
Mr. Saleem Elmasri, CPA
Mr. Saleem Elmasri, CPA
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director Nominee
Independent Director Nominee
--
--
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
äŒç€Ÿå
äŒç€Ÿå/ããžã·ã§ã³
ããžã·ã§ã³
æ ªåŒä¿æ
å€åé¡
Dr. Catherine Do
Dr. Catherine Do
Independent Director Nominee
Independent Director Nominee
100.00K
--
Mr. Saleem Elmasri, CPA
Mr. Saleem Elmasri, CPA
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director Nominee
Independent Director Nominee
--
--
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
åçå èš³
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
äºæ¥å¥
å°åå¥
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
æ ªäž»
æŽæ°æå»: Mon, Nov 17
æŽæ°æå»: Mon, Nov 17
æ ªäž»çµ±èš
çš®é¡
æ ªäž»çµ±èš
æ ªäž»çµ±èš
æ¯ç
Drugs Made In America Acquisition LLC
25.57%
Karpus Investment Management
7.60%
First Trust Capital Management L.P.
6.69%
Polar Asset Management Partners Inc.
5.67%
Glazer Capital, LLC
5.44%
ä»ã®
49.03%
æ ªäž»çµ±èš
æ ªäž»çµ±èš
æ¯ç
Drugs Made In America Acquisition LLC
25.57%
Karpus Investment Management
7.60%
First Trust Capital Management L.P.
6.69%
Polar Asset Management Partners Inc.
5.67%
Glazer Capital, LLC
5.44%
ä»ã®
49.03%
çš®é¡
æ ªäž»çµ±èš
æ¯ç
Hedge Fund
30.25%
Corporation
25.57%
Investment Advisor/Hedge Fund
24.75%
Investment Advisor
5.74%
Research Firm
5.62%
Individual Investor
1.19%
ä»ã®
6.88%
æ©é¢æè³å®¶ä¿ææ ª
îæŽæ°æå»: Mon, Dec 8
æŽæ°æå»: Mon, Dec 8
å ±åæé
æ©é¢æè³å®¶æ°
ä¿ææ ªåŒæ°
æ¯ç
å€åé¡
2025Q4
47
22.21M
67.76%
-8.45K
2025Q3
47
22.22M
67.76%
+1.02M
2025Q2
38
21.21M
54.90%
+2.81M
2025Q1
25
18.33M
0.00%
+18.33M
2024Q4
5
4.59M
15.73%
+4.59M
æ ªäž»åå
îäŒç€Ÿå
ä¿ææ ªåŒæ°
æ¯ç
å€åé¡
å€åç
æ¥ä»
Drugs Made In America Acquisition LLC
8.57M
25.57%
+4.38M
+104.63%
Feb 25, 2025
Karpus Investment Management
2.74M
8.19%
+420.07K
+18.08%
Jun 30, 2025
First Trust Capital Management L.P.
2.24M
6.69%
+175.80K
+8.51%
Jun 30, 2025
Polar Asset Management Partners Inc.
1.90M
5.67%
--
--
Jun 30, 2025
Glazer Capital, LLC
1.82M
5.44%
-502.00
-0.03%
Jun 30, 2025
Westchester Capital Management, LLC
1.67M
4.98%
+690.00K
+70.48%
Jun 30, 2025
Hudson Bay Capital Management LP
1.80M
5.37%
--
--
Jun 30, 2025
Wolverine Asset Management, LLC
1.02M
3.05%
+418.87K
+69.46%
Jun 30, 2025
Mizuho Securities USA, LLC.
919.79K
2.74%
+919.79K
--
Jun 30, 2025
Aristeia Capital, L.L.C.
881.72K
2.63%
-18.28K
-2.03%
Jun 30, 2025
詳现ãèŠã
é¢é£ETF
îæŽæ°æå»: Sat, Dec 6
æŽæ°æå»: Sat, Dec 6
éæå
æ¯ç
CrossingBridge Pre-Merger SPAC ETF
0%
CrossingBridge Pre-Merger SPAC ETF
æ¯ç0%
é åœé
îéå»5幎éã®é
åœéç·æ¯æé¡ã¯
0.00
ç±³ãã«ã§ããã
æ¥ä»
é
åœé
æš©å©ç¢ºå®æ¥
æ¯ææ¥
é
åœèœã¡æ¥
ããŒã¿ãªã
æ ªåŒåå²
îæ¥ä»
çš®é¡
æ¯ç
ããŒã¿ãªã
æ¥ä»
çš®é¡
æ¯ç
ããŒã¿ãªã
ãããã質å
Drugs Made In America Acquisition Corpã®äžäœ5åã®æ ªäž»ã¯èª°ã§ããïŒ
îDrugs Made In America Acquisition Corpã®äžäœ5åã®æ ªäž»ã¯ä»¥äžã®ãšããã§ãã
Drugs Made In America Acquisition LLCã¯8.57Mæ ªãä¿æããŠãããããã¯å šäœã®25.57%ã«çžåœããŸãã
Karpus Investment Managementã¯2.74Mæ ªãä¿æããŠãããããã¯å šäœã®8.19%ã«çžåœããŸãã
First Trust Capital Management L.P.ã¯2.24Mæ ªãä¿æããŠãããããã¯å šäœã®6.69%ã«çžåœããŸãã
Polar Asset Management Partners Inc.ã¯1.90Mæ ªãä¿æããŠãããããã¯å šäœã®5.67%ã«çžåœããŸãã
Glazer Capital, LLCã¯1.82Mæ ªãä¿æããŠãããããã¯å šäœã®5.44%ã«çžåœããŸãã
Drugs Made In America Acquisition LLCã¯8.57Mæ ªãä¿æããŠãããããã¯å šäœã®25.57%ã«çžåœããŸãã
Karpus Investment Managementã¯2.74Mæ ªãä¿æããŠãããããã¯å šäœã®8.19%ã«çžåœããŸãã
First Trust Capital Management L.P.ã¯2.24Mæ ªãä¿æããŠãããããã¯å šäœã®6.69%ã«çžåœããŸãã
Polar Asset Management Partners Inc.ã¯1.90Mæ ªãä¿æããŠãããããã¯å šäœã®5.67%ã«çžåœããŸãã
Glazer Capital, LLCã¯1.82Mæ ªãä¿æããŠãããããã¯å šäœã®5.44%ã«çžåœããŸãã
Drugs Made In America Acquisition Corpã®æ ªäž»ã¿ã€ãäžäœ3çš®ã¯äœã§ããïŒ
îDrugs Made In America Acquisition Corpã®æ ªäž»ã¿ã€ãäžäœ3çš®ã¯ã
Drugs Made In America Acquisition LLC
Karpus Investment Management
First Trust Capital Management L.P.
Drugs Made In America Acquisition LLC
Karpus Investment Management
First Trust Capital Management L.P.
Drugs Made In America Acquisition CorpïŒDMAAïŒã®æ ªåŒãä¿æããŠããæ©é¢ã®æ°ã¯ããã€ã§ããïŒ
î2025Q4æç¹ã§ãDrugs Made In America Acquisition Corpã®æ ªåŒãä¿æããŠããæ©é¢ã¯47瀟ãããä¿ææ ªåŒã®ç·åžå ŽäŸ¡å€ã¯çŽ22.21Mã§ãå
šäœã®67.76%ãå ããŠããŸãã2025Q3ãšæ¯èŒããŠãæ©é¢ã®æã¡æ ªã¯--å¢å ããŠããŸãã
Drugs Made In America Acquisition Corpã®æ倧ã®åçæºã¯äœã§ããïŒ
î--ã«ãããŠã--éšéãDrugs Made In America Acquisition Corpã«ãšã£ãŠæ倧ã®åçãçã¿åºããŠããããã®éé¡ã¯--ã§ãå
šåçã®--%ãå ããŠããŸãã
